GB0328490D0 - Medicinal compounds - Google Patents

Medicinal compounds

Info

Publication number
GB0328490D0
GB0328490D0 GBGB0328490.8A GB0328490A GB0328490D0 GB 0328490 D0 GB0328490 D0 GB 0328490D0 GB 0328490 A GB0328490 A GB 0328490A GB 0328490 D0 GB0328490 D0 GB 0328490D0
Authority
GB
United Kingdom
Prior art keywords
medicinal compounds
medicinal
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0328490.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0328490.8A priority Critical patent/GB0328490D0/en
Publication of GB0328490D0 publication Critical patent/GB0328490D0/en
Priority to PCT/EP2004/013998 priority patent/WO2005058299A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
GBGB0328490.8A 2003-12-09 2003-12-09 Medicinal compounds Ceased GB0328490D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0328490.8A GB0328490D0 (en) 2003-12-09 2003-12-09 Medicinal compounds
PCT/EP2004/013998 WO2005058299A1 (en) 2003-12-09 2004-12-07 Phenethanolamine derivatives for treatment of respiratory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0328490.8A GB0328490D0 (en) 2003-12-09 2003-12-09 Medicinal compounds

Publications (1)

Publication Number Publication Date
GB0328490D0 true GB0328490D0 (en) 2004-01-14

Family

ID=30129875

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0328490.8A Ceased GB0328490D0 (en) 2003-12-09 2003-12-09 Medicinal compounds

Country Status (2)

Country Link
GB (1) GB0328490D0 (en)
WO (1) WO2005058299A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
RU2442771C2 (en) 2005-08-08 2012-02-20 Арджента Дискавери Лтд Derivants of bicyclo[2, 2, 1] hept-7-ylamine and their applications
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
BRPI0923862A2 (en) 2008-12-30 2015-07-28 Pulmagen Therapeutics Inflammation Ltd Sulfonamide compounds for the treatment of respiratory disorders
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
AR083431A1 (en) 2010-06-28 2013-02-27 Bayer Cropscience Ag HETEROCICLICAL COMPOUNDS AS PESTICIDES
JO3192B1 (en) 2011-09-06 2018-03-08 Novartis Ag Benzothiazolone compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
NZ227365A (en) * 1987-12-18 1990-10-26 Glaxo Group Ltd Aromatic amino ethers and pharmaceutical compositions

Also Published As

Publication number Publication date
WO2005058299A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
EG27104A (en) Pharmaceutical compounds
GB0324886D0 (en) Medicinal compounds
GB0315657D0 (en) Pharmaceutical compounds
AU2003244650A8 (en) Medicinal compounds
GB0225540D0 (en) Medicinal compounds
GB0204719D0 (en) Medicinal compounds
GB0225535D0 (en) Medicinal compounds
GB0220730D0 (en) Medicinal compounds
GB0225030D0 (en) Medicinal compounds
GB0303396D0 (en) Medicinal compounds
GB0308511D0 (en) Pharmaceutical compounds
GB0323258D0 (en) Therapeutic compounds
GB0328490D0 (en) Medicinal compounds
GB0317315D0 (en) Pharmaceutical compounds
GB0301736D0 (en) Pharmaceutical compounds
GB0313766D0 (en) Pharmaceutical compounds
GB0329617D0 (en) Pharmaceutical compounds
GB0310361D0 (en) Pharmaceutical compound
GB0328491D0 (en) Medicinal compounds
GB0324889D0 (en) Medicinal compounds
GB0323672D0 (en) Pharmaceutical compounds
GB0329611D0 (en) Pharmaceutical compounds
GB0312509D0 (en) Pharmaceutical compounds
GB0318719D0 (en) Pharmaceutical compounds
GB0324919D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)